lung cancer lead caps cancerrel mortal worldwide lack tumor specify remain major drawback effect chemotherapy result doselimit toxic howe ligandmedi drug delivery system abl render chemotherapy specify cell le toxic normal tissue studi iso novel peptide ligand phagedisplay library bound normal cell oclc line target phage sever synthetic recon surgical specimen post rate sever combine immunodefici said mouse bear xenograft specify mass home bail inhibit cognate control wtymut couple liposom carry doxorubicin vinorelbin therapeutic index chemotherapeut agent survive rate human markedly increase furthermore accueil fold compare free drug enhance apoptosis result higher content bioavail current suggest tumorspecif may use create treatment design target gene transfer vector one diagnosis align 